161 related articles for article (PubMed ID: 10063206)
21. Histological and rheological grading of cutaneous sclerosis in scleroderma.
Piérard GE
Dermatologica; 1989; 179(1):18-20. PubMed ID: 2767293
[TBL] [Abstract][Full Text] [Related]
22. [How I explore ... the skin functional involvement in scleroderma].
Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
[TBL] [Abstract][Full Text] [Related]
23. Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review.
McGaugh S; Kallis P; De Benedetto A; Thomas RM
Dermatol Ther; 2022 Jun; 35(6):e15437. PubMed ID: 35278019
[TBL] [Abstract][Full Text] [Related]
24. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
25. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
Vuorio T; Kähäri VM; Black C; Vuorio E
J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
27. Systemic and localized scleroderma in children: current and future treatment options.
Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
[TBL] [Abstract][Full Text] [Related]
28. Comparative effect of topical silicone gel and topical tretinoin cream for the prevention of hypertrophic scar and keloid formation and the improvement of scars.
Kwon SY; Park SD; Park K
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1025-33. PubMed ID: 23952739
[TBL] [Abstract][Full Text] [Related]
29. Topical tacrolimus in the treatment of localized scleroderma.
Mancuso G; Berdondini RM
Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783
[TBL] [Abstract][Full Text] [Related]
30. [Madecassol treatment of systemic and localized scleroderma].
Guseva NG; Starovoĭtova MN; Mach ES
Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
[TBL] [Abstract][Full Text] [Related]
31. Mechanical evaluation of the resistance and elastance of post-burn scars after topical treatment with tretinoin.
Dematte MF; Gemperli R; Salles AG; Dolhnikoff M; Lanças T; Saldiva PH; Ferreira MC
Clinics (Sao Paulo); 2011; 66(11):1949-54. PubMed ID: 22086527
[TBL] [Abstract][Full Text] [Related]
32. [Scleroderma in children].
Frati Munari AC; Culebro Nieves G; Velázquez E; Podoswa G
Bol Med Hosp Infant Mex; 1979; 36(2):201-14. PubMed ID: 758191
[TBL] [Abstract][Full Text] [Related]
33. Stimulating circulation to end stasis in scleroderma.
Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
[No Abstract] [Full Text] [Related]
34. [Studies on the solubility of skin collagen in scleroderma and the effect of D-penicillamine].
Zimmermann BK; Balda BR
Arch Dermatol Forsch; 1972; 243(4):357-63. PubMed ID: 5079382
[No Abstract] [Full Text] [Related]
35. Clinicopathological study of 81 cases of localized and systemic scleroderma.
Succaria F; Kurban M; Kibbi AG; Abbas O
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e191-6. PubMed ID: 22620486
[TBL] [Abstract][Full Text] [Related]
36. Localized scleroderma: a series of 52 patients.
Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of skin thickness lesions in patients with Lyme disease measured by modified Rodnan total skin score.
Moniuszko A; Gińdzieńska-Sieśkiewicz E; Pancewicz SA; Czupryna P; Zajkowska J; Sierakowski S
Rheumatol Int; 2012 Oct; 32(10):3189-91. PubMed ID: 21960047
[TBL] [Abstract][Full Text] [Related]
38. Nodular morphea.
Kauer F; Simon JC; Sticherling M
Dermatology; 2009; 218(1):63-6. PubMed ID: 19005241
[TBL] [Abstract][Full Text] [Related]
39. Topical calcipotriene for morphea/linear scleroderma.
Cunningham BB; Landells ID; Langman C; Sailer DE; Paller AS
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):211-5. PubMed ID: 9704831
[TBL] [Abstract][Full Text] [Related]
40. Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: An objective histopathological analysis.
Verhaegen PD; van Zuijlen PP; Pennings NM; van Marle J; Niessen FB; van der Horst CM; Middelkoop E
Wound Repair Regen; 2009; 17(5):649-56. PubMed ID: 19769718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
